Genome Editing/Genome Engineering

Global Market Trajectory & Analytics

MCP12163

EXECUTIVE ENGAGEMENTS

POOL

3437
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

619
Interactions with Platform & by Email

PARTICIPANTS

103
Unique # Participated

VALIDATIONS

32
Responses Validated*

COMPANIES

27
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

74

PAGES

131

EDITION

9

PRICE

USD 4950

CODE

MCP12163


COMPETITIVE METRICS

COMPANY

D S N T

% *

Agragene

Login Required

Agribody Technologies, Inc.

Login Required

AI Therapeutics, Inc.

Login Required

Arbor Biotechnologies, Inc.

Login Required

ArsenalBio

Login Required

Axol Bioscience Ltd.

Login Required

Beacon Genomics

Login Required

Benson Hill

Login Required

Bioengineering Lab

Login Required

Biopalette

Login Required

SUBMIT
* D = Dominant; S = Strong; N = Niche; T = Trivial
* Validated respondents are incentivized with cluster data
Note: Best viewed in Landscape Mode
VIEW ENTIRE POOL OF 27 COMPETITORS

Login to access data silos

  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Genome Editing/Genome Engineering estimated at US$4.1 Billion in the year 2020, is projected to reach a revised size of US$10.3 Billion by 2027, growing at a CAGR of 14% over the analysis period 2020-2027. CRISPR, one of the segments analyzed in the report, is projected to record a 14.8% CAGR and reach US$4.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the TALEN segment is readjusted to a revised 14.2% CAGR for the next 7-year period.
The Genome Editing/Genome Engineering market in the U.S. is estimated at US$1.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2027 trailing a CAGR of 13.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.5% and 11.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.1% CAGR.
In the global ZFN segment, USA, Canada, Japan, China and Europe will drive the 12.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$840.5 Million in the year 2020 will reach a projected size of US$1.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.2 Billion by the year 2027.

SELECT PLAYERS

CRISPR Therapeutics AG; Editas Medicine, Inc.; GenScript Biotech Corporation; Horizon Discovery Group PLC; Integrated DNA Technologies (IDT), Inc.; Lonza Group AG; Merck & Co., Inc.; New England Biolabs, Inc.; OriGene Technologies, Inc.; Sangamo Therapeutics; Thermo Fisher Scientific, Inc.; Transposagen Biopharmaceuticals, Inc.

SEGMENTS

» Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Other Applications) » Technology (CRISPR, TALEN, ZFN, Other Technologies)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Genome Editing/Genome Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Genome Editing/Genome Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
World Current & Future Analysis for CRISPR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for CRISPR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for TALEN by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for TALEN by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for ZFN by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for ZFN by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Cell Line Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Cell Line Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Animal Genetic Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Animal Genetic Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Plant Genetic Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Plant Genetic Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Genome Editing/Genome Engineering by Technology - CRISPR, TALEN, ZFN and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Genome Editing/Genome Engineering by Technology - Percentage Breakdown of Value Sales for CRISPR, TALEN, ZFN and Other Technologies for the Years 2020 & 2027
USA Current & Future Analysis for Genome Editing/Genome Engineering by Application - Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Genome Editing/Genome Engineering by Application - Percentage Breakdown of Value Sales for Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications for the Years 2020 & 2027
CANADA
Canada Current & Future Analysis for Genome Editing/Genome Engineering by Technology - CRISPR, TALEN, ZFN and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Genome Editing/Genome Engineering by Technology - Percentage Breakdown of Value Sales for CRISPR, TALEN, ZFN and Other Technologies for the Years 2020 & 2027
Canada Current & Future Analysis for Genome Editing/Genome Engineering by Application - Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Genome Editing/Genome Engineering by Application - Percentage Breakdown of Value Sales for Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications for the Years 2020 & 2027
JAPAN
Japan Current & Future Analysis for Genome Editing/Genome Engineering by Technology - CRISPR, TALEN, ZFN and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Genome Editing/Genome Engineering by Technology - Percentage Breakdown of Value Sales for CRISPR, TALEN, ZFN and Other Technologies for the Years 2020 & 2027
Japan Current & Future Analysis for Genome Editing/Genome Engineering by Application - Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Genome Editing/Genome Engineering by Application - Percentage Breakdown of Value Sales for Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications for the Years 2020 & 2027
CHINA
China Current & Future Analysis for Genome Editing/Genome Engineering by Technology - CRISPR, TALEN, ZFN and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Genome Editing/Genome Engineering by Technology - Percentage Breakdown of Value Sales for CRISPR, TALEN, ZFN and Other Technologies for the Years 2020 & 2027
China Current & Future Analysis for Genome Editing/Genome Engineering by Application - Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Genome Editing/Genome Engineering by Application - Percentage Breakdown of Value Sales for Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications for the Years 2020 & 2027
EUROPE
Europe Current & Future Analysis for Genome Editing/Genome Engineering by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Genome Editing/Genome Engineering by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
Europe Current & Future Analysis for Genome Editing/Genome Engineering by Technology - CRISPR, TALEN, ZFN and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Genome Editing/Genome Engineering by Technology - Percentage Breakdown of Value Sales for CRISPR, TALEN, ZFN and Other Technologies for the Years 2020 & 2027
Europe Current & Future Analysis for Genome Editing/Genome Engineering by Application - Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Genome Editing/Genome Engineering by Application - Percentage Breakdown of Value Sales for Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications for the Years 2020 & 2027
FRANCE
France Current & Future Analysis for Genome Editing/Genome Engineering by Technology - CRISPR, TALEN, ZFN and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Genome Editing/Genome Engineering by Technology - Percentage Breakdown of Value Sales for CRISPR, TALEN, ZFN and Other Technologies for the Years 2020 & 2027
France Current & Future Analysis for Genome Editing/Genome Engineering by Application - Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Genome Editing/Genome Engineering by Application - Percentage Breakdown of Value Sales for Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications for the Years 2020 & 2027
GERMANY
Germany Current & Future Analysis for Genome Editing/Genome Engineering by Technology - CRISPR, TALEN, ZFN and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Genome Editing/Genome Engineering by Technology - Percentage Breakdown of Value Sales for CRISPR, TALEN, ZFN and Other Technologies for the Years 2020 & 2027
Germany Current & Future Analysis for Genome Editing/Genome Engineering by Application - Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Genome Editing/Genome Engineering by Application - Percentage Breakdown of Value Sales for Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications for the Years 2020 & 2027
ITALY
Italy Current & Future Analysis for Genome Editing/Genome Engineering by Technology - CRISPR, TALEN, ZFN and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Genome Editing/Genome Engineering by Technology - Percentage Breakdown of Value Sales for CRISPR, TALEN, ZFN and Other Technologies for the Years 2020 & 2027
Italy Current & Future Analysis for Genome Editing/Genome Engineering by Application - Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Genome Editing/Genome Engineering by Application - Percentage Breakdown of Value Sales for Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications for the Years 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Genome Editing/Genome Engineering by Technology - CRISPR, TALEN, ZFN and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Genome Editing/Genome Engineering by Technology - Percentage Breakdown of Value Sales for CRISPR, TALEN, ZFN and Other Technologies for the Years 2020 & 2027
UK Current & Future Analysis for Genome Editing/Genome Engineering by Application - Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Genome Editing/Genome Engineering by Application - Percentage Breakdown of Value Sales for Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications for the Years 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Genome Editing/Genome Engineering by Technology - CRISPR, TALEN, ZFN and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Genome Editing/Genome Engineering by Technology - Percentage Breakdown of Value Sales for CRISPR, TALEN, ZFN and Other Technologies for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for Genome Editing/Genome Engineering by Application - Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Genome Editing/Genome Engineering by Application - Percentage Breakdown of Value Sales for Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications for the Years 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Genome Editing/Genome Engineering by Technology - CRISPR, TALEN, ZFN and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Genome Editing/Genome Engineering by Technology - Percentage Breakdown of Value Sales for CRISPR, TALEN, ZFN and Other Technologies for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Genome Editing/Genome Engineering by Application - Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Genome Editing/Genome Engineering by Application - Percentage Breakdown of Value Sales for Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications for the Years 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Genome Editing/Genome Engineering by Technology - CRISPR, TALEN, ZFN and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Genome Editing/Genome Engineering by Technology - Percentage Breakdown of Value Sales for CRISPR, TALEN, ZFN and Other Technologies for the Years 2020 & 2027
Rest of World Current & Future Analysis for Genome Editing/Genome Engineering by Application - Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Genome Editing/Genome Engineering by Application - Percentage Breakdown of Value Sales for Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications for the Years 2020 & 2027
Total Companies Profiled: 27

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com